Mild traumatic brain injury (TBI) is the most common type of TBI, and about 30% of patients with mild TBI suffer from symptomatic sequelae for several months to years as post-concussion syndrome. Among the symptoms experienced, mental and cognitive sequelae are particularly intractable.
In recent years, advances in sophisticated MRI techniques have made it possible to visualize small traumatic lesions in living patients with diffuse brain injury (DBI). Diffusion tensor imaging (DTI) has been recognized as the most sensitive modality for detecting white matter injury in DBI. However, in a systematic review of DTI in patients with post-concussion syndrome, 30 and 50% of the reviewed studies showed no significant changes in fractional anisotropy and mean diffusivity, respectively [1]. In another review of DTI, there was a lack of complete agreement on the location and number of affected white matter tracts across different studies of patients with mild TBI [2]. Thus, injury of the white matter in mild TBI remains obscure, even with DTI. Why are the lesions causing symptoms in mild TBI not consistently visible on neuroimaging? We may need to postulate another pathological mechanism apart from the structural lesions shown on MRI as the cause of symptoms in mild TBI.
Brain strain in mild TBI based on injury analysis of a finite element model
The acute phase of a concussion is characterized by a brief loss of consciousness. The force of impact may functionally disrupt normal cellular activity in the reticular activating system in the brainstem. Additionally, vulnerability of the upper brainstem may contribute to disturbances in the pupillary dynamics, accommodation and vergence movements often seen in patients with mild TBI. One likely pathology contributing to these symptoms is damage to the oculomotor and Edinger–Westphal nuclei, both of which are located in the midline structure of the midbrain.
In our recent computational collision injury study using a human head finite element model, which simulates whiplash-associated injury, comparatively higher maximum principal shearing strain values were shown in the corpus callosum and dorsal midbrain (Figure 1) [3]. The results support this pathophysiology as the cause of loss of consciousness and visual dysfunction in mild TBI. The dorsal raphe nucleus (DRN) is also a midline structure of the dorsal midbrain and is located very near the oculomotor and Edinger–Westphal nuclei (Figure 2). According to the collision injury analysis, the DRN is likely highly affected in mild TBI as well. Damage to the DRN may just affect the appearance of symptoms in mild TBI.
Glucose metabolism abnormalities in mild TBI
In patients with severe traumatic DBI corresponding to diffuse axonal injury (DAI), hypometabolic regions detected by 18F-fluorodeoxyglucose PET (18F-FDG-PET) have been consistently reported in the cingulum, medial prefrontal regions, frontal base and medial thalamus during the chronic phase (Figure 3) [4]. However, in our study in a group of patients with chronic mental and cognitive symptoms following mild TBI and without visible brain lesions on MRI, glucose metabolism was significantly reduced across the entire bilateral prefrontal area (Figure 4) [5]. These topographical patterns of glucose hypometabolism are obviously different, and the results suggest that another pathological mechanism distinct from DAI may cause mental and cognitive symptoms in the chronic phase in patients with mild TBI and without visible brain lesions on MRI.
Additionally, our study identified a compensatory increase in glucose metabolism in the limbic system and cerebellum in patients with mild TBI (Figure 4) [5]. This pattern of altered metabolism in patients with mild TBI is topographically similar to that seen in patients with major depressive disorder. Based on these findings, the pathology contributing to mental and cognitive symptoms in the chronic phase of mild TBI is suggested to be similar to that seen in neuropsychiatric diseases, rather than primary axonopathic organic brain damage, as seen with DAI.
Serotonin discharge & acute symptoms following mild TBI
Based on the results of our studies, we hereby propose a hypothesis of altered biphasic serotonin discharge from the DRN as a potential cause of symptoms following mild TBI. The initial pathology is presumed to be the acute damage to the DRN, which results in an abrupt discharge of a large amount of serotonin. This causes transient symptoms, such as a mild type of ‘serotonin syndrome’, including hypertension, tachycardia, tachypnea, mydriasis, agitation and increased neuromuscular tone. The symptoms are often seen in the acute phase of mild TBI, in addition to other symptoms, headache, neck pain, dizziness and nausea, due to the physical damage of the head and upper cervical region.
Serotonin deficiency & post-concussion syndrome
During the several weeks after injury, symptoms improve in most cases of mild TBI, such that normal serotonin secretion from the DRN is presumed to be restored. However, in a certain number of cases, prolonged dysfunction of the DRN may occur, which results in decreased serotonin levels and may lead to decreased activity in numerous brain areas controlled by serotonin projections from the DRN. Serotonin deficiency may then disturb normal mood stabilization in the brain in the chronic phase of mild TBI.
Serotonin deficiency activates the mesolimbic dopamine system via dopamine D2 receptors and causes excessive pleasure- and reward-seeking behavior, which may result in addiction to food, sex and drugs. Some forms of hallucinations and delusions can also occur. Additionally, serotonin deficiency activates the mesocortical dopamine system via dopamine D1 receptors and suppresses function in the prefrontal area, resulting in impairment of cognition, memory and attention. These direct and indirect serotonin deficiency-related symptoms may be seen in the chronic phase in patients with mild TBI as part of post-concussion syndrome. These mechanisms may be supported by the results of our 18F-FDG-PET studies in mild TBI (Figure 4) [5].
Fann et al. reported that selective serotonin reuptake inhibitors improved depressive symptoms as well as cognitive function, with regard to psychomotor speed, cognitive efficiency, flexible thinking and short-term memory, in patients with mild TBI [6,7]. These results also suggest a relationship between the symptoms following mild TBI and serotonin deficiency.
Conclusion
Results from our recent collision injury analysis and 18F-FDG-PET studies led to the hypothesis of altered biphasic serotonin discharge as a potential pathological mechanism of mild TBI [3,5]. Such a hypothesis can be kept in mind as a pathological mechanism for the appearance of symptoms in mild TBI. Further scientific evidence provided by studies using advanced neuroimaging such as serotonin-PET and biochemical studies to monitor serotonin metabolites in the blood and cerebrospinal fluid is needed to verify this hypothesis.
Future perspective
Verification of this hypothesis may lead to establish strategies for protection of brainstem damage in mild TBI including TBI in sports and whiplash-associated injury in traffic accident, and be a clue of medical treatment against serotonin mal-metabolism which can be started in the early phase of mild TBI to prevent deterioration of post-concussion syndrome.
Acknowledgments
The authors thank Dr T Ishibashi for referring a number of patients to the study and for providing the opportunities that facilitated these studies. The authors also thank Taylor & Francis; BMJ Publishing Group Ltd. and Mary Ann Liebert, Inc. for permitting the reuse of figures.
Footnotes
Financial & competing interests disclosure
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending or royalties.
No writing assistance was utilized in the production of this manuscript.
Open access
This work is licensed under the Creative Commons Attribution 4.0 License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
References
Papers of special note have been highlighted as: • of interest
- 1.Khong E, Odenwald N, Hashim Eet al. Diffusion tensor imaging findings in post-concussion syndrome patients after mild traumatic brain injury: a systematic review. Front. Neurol. 7, 156 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Narayana PA. White matter changes in patients with mild traumatic brain injury: MRI perspective. Concussion 2(2), CNC35 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Atsumi N, Iwamoto M, Nakahira Yet al. Investigation of dynamic deformation of the midbrain in rear-end collision using human brain FE model. Comput. Methods Biomech. Biomed. Engin. 15, 1236–1246 (2020). [DOI] [PubMed] [Google Scholar]; • Shows comparatively higher maximum principal shearing strain values in the midbrain in a computational collision injury study using a human head finite element model.
- 4.Nakayama N, Okumura A, Shinoda Jet al. Relationship between regional cerebral metabolism and consciousness disturbance in traumatic diffuse brain injury without large focal lesions: an FDG-PET study with statistical parametric mapping analysis. J. Neurol. Neurosurg. Psychiatry 77, 856–862 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]; • Identifies a characteristic pattern of glucose hypometabolism on positron emission tomography (PET) in patients with diffuse axonal injury in the chronic phase.
- 5.Komura A, Kawasaki T, Yamada Yet al. Cerebral glucose metabolism in patients with chronic mental and cognitive sequelae following a single blunt mild TBI without visible brain lesions. J. Neurotrauma 36, 641–649 (2019). [DOI] [PubMed] [Google Scholar]; • Identifies a characteristic pattern of glucose hypometabolism on PET in patients with mild traumatic brain injury without visible brain lesions on MRI.
- 6.Fann JR, Uomoto JM, Katon WJ. Sertraline in the treatment of major depression following mild traumatic brain injury. J. Neuropsychiatry Clin. Neurosci. 12, 226–232 (2000). [DOI] [PubMed] [Google Scholar]
- 7.Fann JR, Uomoto JM, Katon WJ. Cognitive improvement with treatment of depression following mild traumatic brain injury. Psychosomatics 42, 48–54 (2001). [DOI] [PubMed] [Google Scholar]